Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tendon Adaptations to Training - Effect of Ageing (TAGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03079180
Recruitment Status : Unknown
Verified March 2017 by Jean-Francois GROSSET, Université de Technologie de Compiegne.
Recruitment status was:  Enrolling by invitation
First Posted : March 14, 2017
Last Update Posted : March 14, 2017
Sponsor:
Collaborators:
Centre Hospitalier Compiègne-Noyon
University of Copenhagen
Information provided by (Responsible Party):
Jean-Francois GROSSET, Université de Technologie de Compiegne

Brief Summary:
Tendons are essential structures for transmitting muscle forces to skeletal structures. A stiffer tendon will transmit muscle force faster, and then allow faster movement. Moreover, tendons are a living tissue and respond to mechanical forces by changing their metabolism as well as their structural and mechanical properties. The aim of the present study is to answer essential questions remaining unanswered that are necessary in order to optimize physical activity with ageing in humans, and thus improve quality of life in elderly. The main questions are: What is the minimal training intensity leading to tendon adaptations? What is the time-course of tendon adaptations? Does the same loading protocol lead to similar tendon adaptations for different tendons (Achilles vs Patellar) and does the same training program lead to identical tendon adaptations with age (25yrs vs 75yrs)? To answer these questions, tendon architecture and mechanical properties will be investigated in humans of different age and applying different training intensities. The kinematic of the tendon adaptations due to these different training characteristics will also be investigated. The training protocol will be applied on plantar flexors and knee extensors. MRI and ultrasound techniques as well as the use of ankle and knee ergometers will allow the quantification of possible modifications in tendon architecture and mechanical properties (tendon stiffness and Young's Modulus). This will be assessed in vivo, using ultrasound images to assess tendon displacement during an incremental maximal contraction.

Condition or disease Intervention/treatment Phase
Aging Exercise Training Connective Tissue Skeletal Muscle Other: Strength training at 80% 1RM Other: Strength training at 55% 1RM Not Applicable

Detailed Description:

Given the aging population demographics, and the barriers that exist in this population in terms of exercise participation, determining the level of exercise intensity required and the time-course to induce tendon adaptations is of paramount importance in this population. Therefore the purpose of this study is to:

  1. determine whether a low intensity exercise training program (resistance 55% 1RM) affects tendon architecture and mechanical properties with aging,
  2. compare these effects to those of a higher intensity exercise training protocol (resistance 80% 1RM) with a match training work with regards to the low intensity exercise training group,
  3. evaluate the time course of tendon adaptations (architecture and mechanical properties) for the two training conditions with aging,
  4. compare the effect of an identical training protocol applied on two different muscle groups (triceps surae vs quadriceps muscles) on Patellar and Achilles tendon adaptations.

Every subject recruited (Two groups composed of males aged between 65 and 85 years, and one group of young subjects (between 18 and 30 years)) will be asked to take part in a training program applied on the calf and quadriceps muscle groups on both legs. All subjects will be assessed 4 weeks before starting the intervention program (T-4w), at time zero (T0) and every four weeks during 12 weeks (T4w, and T8w). The investigation 4 weeks before starting the training program will allow using each subject as its own control. The intervention will involve a maximum of forty five (45) minutes training sessions 3 times per week. Subjects will be subjected to the same battery of baseline assessments (T-4w, and T0), during the training procedure (T4w, and T8w), and following the 12-weeks intervention period (T12w).

The effect of aging and different loading interventions on Achilles and Patellar tendon will be investigated for the following parameters:

  • Tendon mechanical properties (stiffness and Young's Modulus) using US technique to assess Achilles and Patellar tendon displacement during an incremental maximal contraction.
  • Tendon architecture using MRI technique to assess Achilles and Patellar tendon cross-sectional area, tendon length and moment arm.
  • Maximal voluntary contraction (MVC)
  • Muscle architecture using MRI technique.

Thus all these data will allow defining an optimal training intensity for physical activity of elderly persons.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Effect of Different Strength Training Intensities on Achilles and Patellar Tendon Adaptations With Aging
Actual Study Start Date : February 13, 2017
Estimated Primary Completion Date : July 28, 2017
Estimated Study Completion Date : July 28, 2017

Arm Intervention/treatment
Experimental: Aged & strength training at 80% 1RM

Subjects: 20 subjects aged between 65 and 85 years

Training programs:

Frequency: 3 training sessions per week. Duration: 12 weeks. Intensity: 80% of one repetition maximum (1RM). The 1RM of the participants in each of the 3 exercises performed in the training program will be reviewed every 2 weeks during training. If 1RM increase, the training load will be adjusted accordingly.

Training exercises: A Warm-up will first be performed on a cycle ergometer during 10min. The training intervention will then consist in performing two sets on each one of the two exercises used for Patellar tendon stress: leg extension and leg press. To stress Achilles tendon, the subjects will perform four (4) sets using a calf raise machine. The subjects will perform 4 to 8 repetitions at 80% 1RM.

All training sessions will take place under appropriate supervision in UTC for the duration of the interventions according to the study design.

Other: Strength training at 80% 1RM
Detailed in Arms section's

Experimental: Aged & strength training at 55% 1RM

Subjects: 20 subjects aged between 65 and 85 years

The training program and training exercises in this group are the same as for the Aged & strength training at 80% 1RM arm except for the two following parameters.

Training intensity: Intensity of exercises will be 55% of one repetition maximum (1RM).

The subjects will perform 6 to 12 repetitions at 55% 1RM.

The two training programs (55% or 80% of 1RM) are designed to be equal in volume (resistance x repetitions x sets).

Other: Strength training at 55% 1RM
Detailed in Arms section's

Experimental: Young & strength training at 55% 1RM

Subjects: 20 subjects aged between 18 and 30 years

The training program and training exercises in this group are the same as for the Aged & strength training at 55% 1RM arm

Other: Strength training at 55% 1RM
Detailed in Arms section's




Primary Outcome Measures :
  1. Time-course change of tendon size [ Time Frame: T-4weeks (4 weeks before starting intervention), T0 (before starting intervention), T+4weeks (after 4 weeks of intervention), T+8weeks (after 8 weeks of intervention), T+12weeks (at the end of the 12 weeks of intervention) ]
    Tendon size (tendon length and cross sectional area (CSA)) will be assessed using MRI.

  2. Time-course change of tendon mechanics (Elastic modulus of the tendon) [ Time Frame: T-4weeks (4 weeks before starting intervention), T0 (before starting intervention), T+4weeks (after 4 weeks of intervention), T+8weeks (after 8 weeks of intervention), T+12weeks (at the end of the 12 weeks of intervention) ]
    Tendon stiffness will be evaluated during voluntary plantar flexion contraction where force and elongation is measured using a force transducer and ultrasound, respectively. Tendon size will be assessed using MRI. Elastic modulus will be calculated based on stiffness and size of tendon.


Secondary Outcome Measures :
  1. Time-course change of plantar flexion muscle strength [ Time Frame: T-4weeks (4 weeks before starting intervention), T0 (before starting intervention), T+4weeks (after 4 weeks of intervention), T+8weeks (after 8 weeks of intervention), T+12weeks (at the end of the 12 weeks of intervention) ]
    Plantar flexion muscle strength will be assessed using a specifically designed ankle ergometer under isometric contraction.

  2. Time-course change of calf muscle size [ Time Frame: T-4weeks (4 weeks before starting intervention), T0 (before starting intervention), T+4weeks (after 4 weeks of intervention), T+8weeks (after 8 weeks of intervention), T+12weeks (at the end of the 12 weeks of intervention) ]
    Calf muscle size (i.e. cross sectional area and volume) will be assessed using MRI.

  3. Time-course change of quadriceps muscle strength [ Time Frame: T-4weeks (4 weeks before starting intervention), T0 (before starting intervention), T+4weeks (after 4 weeks of intervention), T+8weeks (after 8 weeks of intervention), T+12weeks (at the end of the 12 weeks of intervention) ]
    Quadriceps muscle strength will be assessed using a specifically designed knee ergometer under isometric contraction.

  4. Time-course change of quadriceps muscle size [ Time Frame: T-4weeks (4 weeks before starting intervention), T0 (before starting intervention), T+4weeks (after 4 weeks of intervention), T+8weeks (after 8 weeks of intervention), T+12weeks (at the end of the 12 weeks of intervention) ]
    Quadriceps muscle size (i.e. cross sectional area and volume) will be assessed using MRI.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Males
  • Age between 18 and 30 years for the young group and between 65 and 85 years for aged group
  • Physical and mental health, as assessed by clinical investigation
  • Written informed consent
  • Willingness to co-operate
  • Non-smoker
  • Not addicted to alcohol or drugs
  • Habitual sedentary/low physical activity levels

Exclusion Criteria:

  • BMI <20 or >28
  • Height <155cm, >195cm
  • Chronic disease with regular clinical treatment
  • Regular drug intake
  • Any metabolic or hormonal disorder
  • Psychiatric conditions
  • Any blood clotting disorder
  • Any muscle or bone disease
  • Metal implants
  • Any inflammatory disease
  • Metabolic or hormonal disorder
  • Participation in sports at competitive rather than at a recreational level
  • Fractures during the past 6 months
  • Epilepsy
  • Back pain
  • Lower extremity trauma during the past 6 months, or currently experiencing related symptoms, or receiving treatment
  • Any other condition or history that the investigator considers might increase the risk to the individual or interfere with the evaluation of data

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03079180


Locations
Layout table for location information
France
Universite de Technologie de Compiegne
Compiegne, France, 60200
Sponsors and Collaborators
Université de Technologie de Compiegne
Centre Hospitalier Compiègne-Noyon
University of Copenhagen
Investigators
Layout table for investigator information
Principal Investigator: Franck Mabesoone, MD Centre Hospitalier Compiegne-Noyon
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Jean-Francois GROSSET, Associate Professor (PhD), Université de Technologie de Compiegne
ClinicalTrials.gov Identifier: NCT03079180    
Other Study ID Numbers: 2016-A00534-47
First Posted: March 14, 2017    Key Record Dates
Last Update Posted: March 14, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Jean-Francois GROSSET, Université de Technologie de Compiegne:
Tendon
Ageing
Training
Achilles tendon
Patella tendon
Skeletal muscle
Adaptation
Triceps Surae
Quadriceps